Live from the NIH registry
Studies recruiting near Glendale right now
Top 25 of 2,959 recruiting studies, sorted by proximity — each links to its official registry page
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (9.0 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (9.0 mi)
· Sponsor: Westat
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135) — Burbank, California (3.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (9.0 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Global Research Management — Glendale, California (2.8 mi)
· Sponsor: Boehringer Ingelheim
Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)
Actinic Keratosis (AK)
N/A
Observational 30 participants sought
Ablon Skin Institute and Research Center — Manhattan Beach, California (22.6 mi)
· Sponsor: Avant Health LLC
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
California Eye Specialists Medical group Inc. — Pasadena, California (6.3 mi)
· Sponsor: Genentech, Inc.
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Eye Physicians of Long Beach — Long Beach, California (28.9 mi)
· Sponsor: VisionCare, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Los Angeles — Los Angeles, California (9.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (9.0 mi)
· Sponsor: AbbVie
Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health
Cognitive Decline
N/A
Observational 150 participants sought
People Science — Los Angeles, California (9.0 mi)
· Sponsor: M2 Ingredients
Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants
Movement Disorders, Neurorehabilitation
N/A
Interventional 50 participants sought
UCLA Neural Engineering and Computation Lab — Los Angeles, California (9.0 mi)
· Sponsor: University of California, Los Angeles
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Southern California Permanente Medical Group — Bellflower, California (22.0 mi)
· Sponsor: Mirati Therapeutics Inc.
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
Advanced Cancer, Solid Tumor
Phase 1
Interventional 26 participants sought
City of Hope National Medical Center — Duarte, California (15.7 mi)
· Sponsor: Proviva Therapeutics, Inc.
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy
Phase 2
Interventional 120 participants sought
City of Hope Medical Center — Duarte, California (15.7 mi)
· Sponsor: City of Hope Medical Center
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
Postpartum Hypertension (PPHT)
Phase 4
Interventional 110 participants sought
UCLA Ronald Reagan — Los Angeles, California (9.0 mi)
· Sponsor: University of California, Los Angeles
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (17.9 mi)
· Sponsor: Astellas Pharma Inc
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Glendale, California (2.8 mi)
· Sponsor: Daiichi Sankyo
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Children With Medical Complexity (CMC), Multiple Chronic Conditions
N/A
Interventional 110 participants sought
Children's Hospital Los Angeles — Los Angeles, California (9.0 mi)
· Sponsor: University of Utah
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Southern California — Los Angeles, California (9.0 mi)
· Sponsor: AB Science
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
Acute Lymphoblastic Leukemia
N/A
Observational 500 participants sought
Los Angeles General Medical Center — Los Angeles, California (9.0 mi)
· Sponsor: University of Southern California
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California (3.6 mi)
· Sponsor: SWOG Cancer Research Network
Housing Transitions QUERI
Homelessness
Phase 1
Interventional 153 participants sought
VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California (14.1 mi)
· Sponsor: VA Office of Research and Development
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Sylmar, California (14.5 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
Berenson Cancer Center — West Hollywood, California (9.1 mi)
· Sponsor: C4 Therapeutics, Inc.